Richard Spector
Corporate Officer/Principal at FEMASYS INC.
Net worth: - $ as of 2024-05-30
Profile
Richard Spector's current job is as the Chief Commercial Officer at Femasys, Inc. He previously worked as the Senior Director-Strategic Alliances at Insulet Corp., the Chief Commercial Officer at QLibrium, Inc., and the Vice President-Global Sales & Partner Development at OvaScience, Inc. Mr. Spector obtained his undergraduate degree from The California State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FEMASYS, INC.
-.--% | 2024-02-11 | 0 ( -.--% ) | - $ | 2024-05-30 |
Richard Spector active positions
| Companies | Position | Start |
|---|---|---|
| FEMASYS INC. | Corporate Officer/Principal | 2024-01-31 |
Former positions of Richard Spector
| Companies | Position | End |
|---|---|---|
| INSULET CORPORATION | Corporate Officer/Principal | - |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Sales & Marketing | - |
QLibrium, Inc.
 QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Corporate Officer/Principal | - |
Training of Richard Spector
| The California State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FEMASYS INC. | Electronic Technology |
| INSULET CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
QLibrium, Inc.
QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Distribution Services |
- Stock Market
- Insiders
- Richard Spector
